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Although the precisemechanism underlying initial lesion development inmultiple sclerosis
(MS) remains unclear, CNS inflammation has long been associated with demyelination,
and axonal degeneration. The activation of microglia/macrophages, which serve as
innate immune cells in the CNS, is the first reaction to even minor pathologic changes
in the CNS and is considered an initial pathogenic event in MS. Microglial activation
accompanies a variety of gene expressions, including cystatin F (Cys F), which belongs
to the cystatin superfamily and is one of the cathepsin inhibitors. In our previous study
we showed that Cys F has a unique expression pattern in microglia/macrophages in the
demyelination process. Specifically, the timing of Cys F induction correlated with ongoing
demyelination, and the sites of Cys F expression overlapped with areas of remyelination.
Cys F induction ceased in chronic demyelination when remyelination capacity was lost,
suggesting that Cys F expressed bymicroglia/macrophagesmay play an important role in
demyelination and/or remyelination. The functional role of Cys F in demyelinating disease
of the CNS, however, is unclear. Cys F gene knockout mice were used in the current study
to clarify the functional role of Cys F in the demyelination process in a cuprizone-induced
demyelination animal model. We demonstrated that absence of the Cys F gene and
the resulting disinhibition of cathepsin C (Cat C) aggravates the demyelination, and this
findingmay be related to the increased expression of the glia-derived chemokine, CXCL2,
which may attract inflammatory cells to sites of myelin sheath damage. This effect was
reversed by knock down of the Cat C gene. The findings gain further insight to function
of Cat C in pathophysiology of MS, which may have implications for therapeutics for the
prevention of neuroinflammation-involved neurological disorders in the future.
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INTRODUCTION
Myelin is a spiral multi-layered structure that is wrapped
around the neuron axonal surface. Myelin is produced by
oligodendrocytes and is characterized by important effects,
such as accelerating nerve conduction velocity, insulation, and
neurotrophy in the central nervous system (CNS). Myelin of
the CNS is susceptible to a variety of metabolic, toxic, and
autoimmune insults, which can lead to demyelination of axons
and result in dysfunctional movement, cognition, and sensation.
Multiple sclerosis (MS) is a common demyelinating disease of
the CNS. Although the precise mechanism underlying initial
lesion development in MS is unclear, the CNS inflammation is
characterized by increased glial activation, pro-inflammatory
cytokine concentrations, blood-brain-barrier permeability,
and leukocyte invasion, and long been associated with
demyelination and axonal degeneration, which are the
hallmarks of MS (Lassmann et al., 2007). The activation of
microglia/macrophages, which serves as innate immune cells
in the CNS, is the first reaction to even minor pathologic
changes in the CNS (Kreutzberg, 1996) and is considered an
initial pathogenic event in MS (Singh et al., 2013). Microglial
activation accompanies a variety of gene expressions and may
cause myelin/axonal damage. Alternatively, microglia may
clean up damaged myelin/axonal debris, which promotes
remyelination (Lampron et al., 2015). In our previous study,
using cDNA microarray analysis and other molecular biology
and morphologic methods, we found changes in the expression
of numerous genes during the demyelination process, such
as cathepsins, which have been shown to play a significant
role in inflammatory responses, induction of cytokines, and
tissue damage (Ma et al., 2007; Conus and Simon, 2010;
Perišic´ Nanut et al., 2014). The cathepsins family is found
primarily in lysosomes and plays key roles in intracellular
degradation of proteins and peptides. This view has been
broadened because cathepsins are involved in a number of
important cellular processes, such as antigen presentation, bone
resorption, apoptosis, and protein processing, as well as several
pathologic events, such as cancer progression, inflammation, and
neurodegeneration (Magister and Kos, 2013). Under physiologic
conditions, the activity of the cathepsins is strictly regulated by
cystatins, which are the endogenous inhibitors of cathepsins and
act as one of the main means of regulation. A broad spectrum
of biological roles has been suggested for cystatins, including a
role in protein catabolism, regulation of hormone processing
and bone resorption, inflammation, antigen presentation, and
T-cell dependent immune responses, and resistance to various
bacterial and viral infections (Magister and Kos, 2013). Cystatins
have been suggested to serve as modulators of the proteolytic
system in several diseases (Magister and Kos, 2013), including
demyelinating diseases (Ma et al., 2007, 2011; Sladkova et al.,
2011; Duan et al., 2012). Cystatin F (Cys F), which belongs
to the cystatin superfamily, is a cathepsin inhibitor. In our
previous study we reported that Cys F has a unique pattern
of expression in microglia/macrophages in the demyelination
process. The timing of Cys F induction correlated with ongoing
demyelination, and the sites of Cys F expression overlapped
with the remyelination areas. Induction of Cys F ceased in
chronic demyelination when the remyelination capacity was lost,
suggesting that Cys F expressed by microglia/macrophages may
play an important role in demyelination and/or remyelination
(Ma et al., 2011). Predating our study, Cys F was identified as
an up-regulated gene after lipopolysaccharide (LPS) stimulation
of monocyte-derived dendritic cells (Hashimoto et al., 2000)
and was independently designated as a cystatin-like metastasis-
associated protein, the level of expression of which is correlated
with metastatic potential in liver tumors (Morita et al., 2000).
We have described in detail the pattern of Cys F expression in
microglia/macrophages in the CNS of several demyelinating
animal models and in the spinal cord tissues of MS patients
(Ma et al., 2011); however, the functional role of Cys F in
demyelinating diseases of the CNS is unclear.
Using Cys F gene knockout mice, we clarified the functional
role of Cys F during the demyelination process in a cuprizone-
induced demyelination animal model. We demonstrated that
lack of the Cys F gene and the resulting disinhibition of cathepsin
C (Cat C) aggravates the demyelination status, and this may be
related to increased expression of the glia-derived chemokine,
CXCL2, which may attract inflammatory cells to sites of myelin
sheath damage. This effect was reversed by knock down of the
Cat C gene.
MATERIALS AND METHODS
Animals
Homozygote B6 and 129-Cst7tm1Ayr/J (Cys F KO) mice were
purchased from the Jackson Laboratory (stock no. 008157)
and CatC STOP-tetO mice (Cat STOP-tetO/+; C57BL/6
background) and Iba1-tTA mouse line 75 (initial BDF1
background backcrossed to C57BL/6 background) were kindly
provide by Professor Ikenaka. Cys F KO mice and their
wild-type littermates were used after mating with C57BL/6
mice (provided by Dalian Medical University) repeatedly for
five generations. Genotyping of the Cys F KO, Iba1-tTA,
and CatC STOP-tetO mice were determined by restriction
fragment length polymorphism analyses. The primers used
for mouse genotyping are shown in Table 1. Cys F KO
and Cat CSTOP−tetO/STOP−tetO (Cat C KD) mice were used
to establish a cuprizone-induced demyelination model by
feeding 0.2% cuprizone (Sigama, MO, USA) for 4 weeks.
The wild-type littermates were used as a control group.
All procedures were in accordance with the Dalian Medical
University Guidelines for the Care and Use of Laboratory
Animals and were approved by the Laboratory Animal Care and
Use Committee of Dalian Medical University. Each group had
at least three mice. All efforts were made to minimize animal
suffering.
Tissue Preparation
Mice were anesthetized with 0.4% chloralhydrate, then some
were perfused with cold phosphate-buffered saline (PBS;
Coolaker, Beijing, China). The brains were removed for
protein and mRNA collection. Other mice were perfused
with 4% paraformaldehyde in PBS solution. The brains were
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TABLE 1 | Sequences of primers for real time-PCR.
Gene Sequences of primers Product
size (bp)
cytatin F 5′-AGGAAAGGAAGAGGGTTGCCTGAA-3′ 415
5′-TCATGTGTTCATGGTTGGGAGGGA-3′
neomysin 5′-CTTGGGTGGAGAGGCTATTC-3′ 280
5′-AGGTGAGATGACAGGAGATC-3′
cathepsin C 5′-TTCCACGGAGTCAGAAATGCAGGA-3′ 1283
5′-GAGCCAAGTGTTAGGCATTGCGTT-3′
Cat C STOP-tetO 5′-AGCAGAGCTCGTTTAGTGAACCGT-3′ 895
5′-GAGCCAAGTGTTAGGCATTGCGTT-3′
Iba1-tTA 5′-ATGCCTGGGAGTTAGCAAGGGAAT-3′ 380
5′-CGGAGTTGATCACCTTGGACTTGT-3′
removed and stored at 4◦C in the same fixative overnight.
Then, the brains were transferred into PBS containing 20%
sucrose (Amrzsco, OH, USA) overnight, embedded in OCT
compound (Sakuro Finetek, CA, USA), and cut into 18µm
slices. Coronary brain sections were cut for IHC and myelin
staining.
Cell Cultures
The primary mixed glial cells were prepared from neonatal
C57BL/6J mouse pups as reported previously (Ma et al., 2011). In
brief, after carefully removing the meninges, the neonatal brain
was disintegrated by pipetting. The cell suspension was seeded in
10-cm culture dishes at a density of one brain per dish. Dulbecco’s
modified eagle medium (DMEM, 10mL; Sigma, St. Louis, MO,
USA) containing 10% fetal bovine serum (FBS; ICN Biomedicals,
Aurora, OH, USA) was added to each dish. After14 days in vitro,
primary mixed glial cells were dissociated by trypsinization, and
the cell suspension was plated in 15.6-mm culture dishes for
treatment with Cat C (R&D Systems, Minneapolis, MN, USA);
each culture dish contained 1× 106 cells.
Immunohistochemical (IHC) Staining
IHC analysis was performed as described previously (Ma
et al., 2011). The following antibodies were used: rat anti-PLP
monoclonal antibody (1:1, clone AA3) (Yamamura et al., 1991),
goat anti-Cat C antibody (1:100 R&D Systems), rabbit anti-Iba-1
polyclonal antibody (1:500; Wako, Osaka, Japan), rat anti-myelin
basic protein monoclonal antibody (1:200; Abcam, Hong Kong,
China), and mouse anti-adenomatous polyposis coli (CC-1)
monoclonal antibody (1:50; Calbiochem, Darmstadt, Germany).
Secondary antibodies were labeled with biotin antibodies (1:200;
Vector Laboratories Inc., Burlingame, CA, USA). After the IHC
reaction, images were captured using a Nikon digital camera
system (DS-Fil) united with microscopy (Nikon eclipse 80i;
Tokyo, Japan).
In situ Hybridization
The method of in situ hybridization (ISH) was performed as
described previously (Ma et al., 2006). We used digoxigenin
(DIG)-labeled Cat C (NM_009982, 193–1324 bp), c-fms (EST
clone, AA473814, Invitrogen, CA, USA) cRNA probes. Samples
were incubated overnight with alkaline phosphatase-conjugated
anti-DIG antibody (Roche, Basel, Switzerland) at 4◦C. After
hybridization of antisense cRNA probes, dyeing was completed
by incubation with 4-nitro blue tetrazolium chloride/5-bromo-
4-chloro-3-indolyl-phosphate (NBT/BCIP) (Roche Diagnostic
Gmbh, Mannheim, Germany) for 16 h at room temperature.
Some sections were then stained with Nuclear Fast Red for survey
and analysis. Three sections from each mouse were used for
analysis.
Myelin Staining
Black-gold staining was performed according to a protocol
adapted from the manufacturer (Millipore, Billerica, MA, USA).
In brief, three sections from each mouse were stained in pre-
heated 0.3% black-gold solution in a 65◦C incubator for 45min.
The sections were then immersed in 1% sodium thiosulfate
solution in a 65◦C incubator for 20min.
DNA Extraction and Genotyping
The DNA was extracted from the mouse tail using a heat
extraction method (Ma et al., 2011). The PCR was performed in
10µl volumes containing 1 ul dNTPs (2.5mM), 0.5µl of each
primer, 0.05µl of Taq DNA polymerase, 1µl of 10 × buffer with
0.5µl of DNA, and Milli-Q water. Amplification was performed
using reaction components with an initial denaturation at 95◦C
for 1min, then 39 cycles at 95◦C for 30 s, 60◦C for 30 s, and
72◦C for 45 s, followed by extension at 72◦C for 60 s. The PCR
outcome was subjected to 2% agarose gel electrophoresis and the
consequences were analyzed by a gel imaging and analysis system.
Real-Time Quantitative PCR
Total RNA was extracted from the brain and primary mixed
glial cells (1 × 106) with Trizol reagent (Invitrogen, CA, USA)
according to the manufacturer’s protocol. The RevertAid First
Strand cDNA Synthesis Kit (Thermo Scientific Grand Island,
NY, USA) was used to synthesize cDNA from 1µg of total
RNA. The cDNA was resuspended in 20µl of H2O, and 2µl of
cDNA samples were used for real-time PCR in a total volume of
25µl with SYBRGreen Reagent (Thermo Scientific Grand Island,
NY, USA), ROX (Thermo Scientific Grand Island, NY, USA)
and specific primers (Table 1). Results for each sample were
normalized to the concentration of β-actin mRNA measured in
the same samples and expressed as the fold increase over baseline
levels on control samples from naïve mice and untreated mixed
glial cells, which were set at a value of 1.
Enzyme-Linked Immunosorbent Assay
(ELISA)
Cys F KO and littermate wild-type mice were treated with
cuprizone for 4 weeks. Total brain protein was extracted
using a KeyGEN Nuclear and Cytoplasmic Protein Extraction
Kit (KeyGEN BioTECH, Nanjing, China) following the
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FIGURE 1 | The remaining myelin status in wild type and Cys F KO mice after cuprizone treatment for 4 weeks. PLP IHC and Black Gold staining were
performed in the untreated mice (A,E), cuprizone-treated wild type mice (B,F) and Cys F KO mice (C,G), respectively. Percentage of remaining myelin in corpus
callosum is shown in (D,H). *P < 0.05, **P < 0.01. n = 6 per group. Scale bar in (A–C) and (E–G): 200µm.
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manufacturer’s protocol. The other samples were primary mixed
glial cells under the same conditions as above, prior to treatment
with different doses of Cat C (560, 56, 5.6, and 0.56 ng) for
24 h. After treatment, a MIP-2 (CXCL2) ELISA Kit (Abcam)
was used for quantitative analysis of MIP-2 in brain and the
primary mixed glial cell cultures, according to the manufacturer’s
protocol.
Image Analysis
After black-gold or PLP and Cat C IHC staining, according to the
mouse brain atlas (Keith B. J. Franklin & George Paxinos), three
coronary brain sections per animal around the bregma (−1.46 to
−1.50 mm) were selected, then three high magnification images
were captured randomly in the corpus callosum (CC) using
identical exposure times and camera settings to quantify the
myelin status and Cat C-positive area using Image J (National
Institutes of Health) software. The main process includes
changing the color images into 32 bit black-white images, then
three rectangular areas per image were randomly selected, the
threshold was set, and the staining signal existing area was
labeled and measured. The ratio value of the MBP, PLP, or Cat
C positive signal area to the total area in the rectangle was
used for statistical analysis. Additionally, three or four mice were
chosen for calculation of c-fms (n = 4) and Cat C (n = 3)
positive signals in ISH staining, as well as CD 45 (n= 4) positive
signals in IHC staining. Three high magnification images were
captured in the middle part of CC in each mouse, and three fields
were chosen randomly in each image. NIS-Elements 3.0 software
was used to calculate the number of positive signals per mm2
field.
Statistical Analysis
Data are expressed as the mean ± standard error of the
mean (SEM) from three independent experiments. All statistical
analyses were performed using the Statistical Package for Social
Sciences (version 11.5). The data were evaluated for statistical
significance with a one-way ANOVA. P < 0.05 was considered
statistically significant.
RESULTS
Cuprizone-Induced Demyelination Was
More Severe in Cys F KO Mice
To clarify the functional role of Cys F in the demyelination
process, a cuprizone-induced acute demyelinating model was
generated in wild and Cys F KO mice. According to the time
window in the cuprizone model (Mason et al., 2001), most axons
were demyelinated after 4 weeks of a cuprizone diet. Thereafter,
remyelination coincided with demyelination even in the
presence of continuous cuprizone. To distinguish demyelination
from the remyelination process, the demyelination status was
analyzed by PLP IHC (Figures 1A–C) and Black Gold staining
(Figures 1E–G) in the present study after the mice were fed
with cuprizone for 4 weeks; untreated wild-type and Cys
F KO littermates were used as the control. There were no
significant differences between the untreated wild type and
Cys F KO mice with PLP IHC or Black Gold staining
(Supplementary Figures 1A–C,G,H,J), while after cuprizone
feeding, massive demyelination in the corpus callosum and bits
of demyelination in the hippocampus occurred in Cys F KO and
wild-type mice. Quantitative comparison of the residual myelin
(Figures 1D,H) showed that Cys F KO mice had more robust
demyelination than wild type mice following cuprizone feeding.
These results indicate that knockout of the Cys F gene aggravates
cuprizone-induced demyelination in the brain.
Cat C Expression Was Up-Regulated in Cys
F KO Mice Fed with Cuprizone for 4 Weeks
Previous reports have shown that Cat C is a major target of
Cys F in different immune cell types. Cat C can activate serine
proteases in T cells, natural killer cells, neutrophils, and mast
cells (Hamilton et al., 2008). Also, we previously found Cat
C is predominantly expressed in hippocampal CA2 neurons
in normal mice, but up-regulated in activated microglia in
neuroinflammation induced by LPS intraperitoneal injection
(Fan et al., 2012). Taken together, we believed that knockout
of Cys F aggravated cuprizone-induced demyelination might
FIGURE 2 | The expression of Cat C mRNA and protein in corpus
callosum in wild type and Cys F KO mice treated by cuprizone for 4
weeks. Cat C ISH (A–C) and Cat C IHC (D–F) staining were performed in the
untreated mice (A,D), cuprizone-treated wild type (B,E) and Cys F KO mice
(C,F). Percentages of Cat C ISH and Cat C IHC positive cells in corpus
callosum are shown in (G,H), respectively. *P < 0.05, **P < 0.01. n = 3 per
group. Scale bar in (A–F): 200µm.
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be related to Cat C expression. Therefore, we first performed
in situ hybridization (ISH; Figures 2A–C) and IHC staining
(Figures 2D–F) for Cat C. No Cat C-positive signals in CC and
cortex in untreated mice, including wild type (Figures 2A,D)
and Cys F KO mice (Supplementary Figures 2A,B), but massive
Cat C expression was seen in demyelinated areas, such as the
CC and cortex. Cat C mRNA-positive cells (Figure 2G) and the
ratio of the Cat C IHC-positive area-to-total area (Figure 2H)
in the CC were quantified for statistical analysis after cuprizone
treatment for 4 weeks. Cat C-positive cells in Cys F KOmice were
significantly greater than wild type mice (Figures 2G,H). These
results confirmed our speculation that severe demyelination in
Cys F KOmice might be related to up-regulated Cat C expression
in demyelinated areas.
More Microglia/Macrophages
Accumulated in the Cuprizone-Induced
Demyelinated Areas in Cys F KO Mice
In our previous study, the up-regulated expression of Cat
C was mainly found in microglia/macrophage lineage cells
in LPS–induced neuroinflammation (Fan et al., 2012). To
further confirm the cellular source of Cat C, we performed
c-fms ISH and Iba-1 IHC staining, which are commonly
used as a marker of microglia/macrophages, to detect
microglia/macrophages in wild and Cys F KO mice after
cuprizone treatment. After 4 weeks of cuprizone feeding, masses
of microglia/macrophages accumulated at the demyelinated
areas (Figures 3A–F), and the number in Cys F KO mice
overwhelmed the wild-type littermates (Figure 3H). However,
the number of microglia/macrophages in untreated Cys F KO
mice were similar to that in the untreated wild-type littermates
(Supplementary Figures 3A–F). Further, double staining of
Cat C ISH and Iba-1 IHC staining demonstrated that Cat C is
expressed in microglia/macrophages (Figure 3G). These data
demonstrated that up-regulated expression of Cat C reflects the
increased density of microglia/macrophages in Cys F KO mice.
Additionally, we performed CD45 IHC staining. CD45 is the
leukocyte common antigen expressed by all hematopoietic cells,
except erythrocytes. We found that in normal CC, there were
almost no CD45-positive cells (Figure 4A), while a large number
of CD45-positive cells appeared inmice fed cuprizone for 4 weeks
(Figures 4B,C). Moreover, the number of CD45-positive cells
in Cys F KO mice was much greater than wild-type littermates
(Figure 4D). Meanwhile, no significant difference for the number
of CD45-positive cells was found between untreated Cys F KO
mice and wild-type littermates (Supplementary Figures 4A–C).
Furthermore, using Iba-1 and CD45 double staining in Cys
F KO mice after cuprizone treatment (Figures 4E–G), we
found that almost all of the Iba-1-positive cells were CD45-
positive (shown by arrowhead). These results demonstrated
that leukocytes including monocytes/macrophages aggregated
FIGURE 3 | The accumulation of microglia/macrophagesin corpus callosum in wild type and Cys F KO mice after cuprizone treatment for 4 weeks.
Iba-1 IHC (A–C) and c-fms ISH (D–F) staining were performed in untreated mice (A,D), 4 week-cuprizone treated wild type (B,E) and Cys F KO mice (C,F). The
double staining of Cat C IHC and Iba-1 IHC staining is seen in (G). Quantitative analysis result of c-fms positive cells in corpus callosum is shown in (H). *P < 0.05,
**P < 0.01. n = 4 per group. Scale bar in (A–F): 200µm.
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FIGURE 4 | CD45 positive cells in wild type and Cys F KO mice treated by cuprizone for 4 weeks. CD45 IHC was performed in untreated wild type mice (A),
4 week- cuprizone treated wild type (B) and Cys F KO mice (C), respectively. Quantitative analysis of CD45 positive cells in corpus callosum is shown in (D). Iba-1 and
CD45 immunofluorescence staining is shown in (E–G), the arrows showed Iba-1 and CD45 double staining cells. *P < 0.05, **P < 0.01. n = 4 per group. Scale bar in
(A–C): (E) 200µm; in (E) 10µm.
in the cuprizone-induced demyelinated areas in Cys F KO
mice.
Expression of CXCL2 Was Clearly
Increased after Cuprizone Treatment in
Cys F KO Mice
Thus far, we found the following in Cys F KO mice after
cuprizone treatment: (1) aggravated demyelination status; (2) Cat
C was mainly derived from microglia/macrophages; and (3) a
greater number of leukocytes including monocytes/macrophages
accumulated in the demyelinated areas. Cat C has been proved
to take part in the release of chemokines, and Cat C gene could
deficiency decreases the release of CXCL2 in the peripheral
circulation (Pagano et al., 2007). Because CXCL2 is produced
by leukocytes (Gu et al., 1999) in the circulatory system, and by
microglia/macrophages (Wang et al., 2000; Rouault et al., 2013)
and astrocytes (Wang et al., 2014) in the CNS, we were curious
about the level of CXCL2 expression in wild and Cys F KO mice
after cuprizone treatment. Therefore, real-time quantitative PCR
and ELISA were preformed to detect the expression of CXCL2
mRNA and protein, respectively. There were no significant
differences between untreated wild type and Cys F KO mice
(Supplementary Figures 5A,B), while after 4 weeks of cuprizone
feeding, the expression of both CXCL2 mRNA and protein were
prominently increased compared to untreated mice, and the
highest level of CXCL2 existed in Cys F KOmice (Figures 5A,B).
These results suggest that cuprizone treatment significantly
increased CXCL2 expression, whichmight be related to increased
accumulation ofmicroglia/macrophages in cuprizone treated Cys
F KO mice.
Cat C Stimulated Glial Cells to Produce
CXCL2
Because the major inhibitory target of Cys F is Cat C, and
up-regulated expression of Cat C has been found in Cys F
KO mice, all of these findings implied a possible correlation
between Cat C and increased CXCL2 expression. It is known
that Cat C is involved in the release of CXCL2 in the peripheral
circulation (Pagano et al., 2007). Therefore, we asked whether
Cat C was also involved in CXCL2 production in the CNS. We
used a recombination monomer of Cat C to stimulate primary
cultured glial cells in vitro, then we found that both mRNA and
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FIGURE 5 | The mRNA and protein expression of CXCL2 in wild type
and Cys F KO mice after 4-week cuprizone treatment. RNA and protein
were isolated from brain tissues of untreated wild type mice and 4
week-cuprizone feeding wild type and Cys F KO mice, respectively. CXCL2
mRNA and protein were measured by real-time quantitative PCR and ELISA.
The results are shown in (A,B), respectively. *P < 0.05, **P < 0.01. n = 5 per
group.
protein of CXCL2 was increased with increased doses of Cat C.
(Figures 6A,B) These results suggested that Cat C stimulates glial
cells to produce CXCL2 in vitro.
Cat C Gene Knock Down Decreased
CXCL2 Expression and Accumulation of
Microglia/Macrophages
Based on the aforementioned results, we raised the hypothesis
that a lack of the Cys F gene removed inhibition of Cat C,
thus resulting in more chemokine CXCL2 release from glial
cells and accumulation of inflammatory cells and led to severe
demyelination. To testify our hypothesis, we used transgenic
mouse lines in which Cat C gene expression can be manipulated
by the FAST system (Tanaka et al., 2010). Because of the STOP
sequence forcing termination of transcription of Cat C, the
homozygotes of the STOP-tetO knock-in alleles in the absence
of the tTA allele (Cat CSTOP−tetO/STOP−tetO) should behave
as Cat C knockdown (KD) mice (submitted for publication).
We used Cat C KD mice to generate the cuprizone model
again. We found no significant differences in CXCL2 mRNA
FIGURE 6 | The expression and release of CXCL2 in mix-cultured glial
cells following active recombinant Cat C stimulation. CXCL2 mRNA and
protein expression in mix-cultured glial cells stimulated by active recombinant
Cat C in different concentrations were measured by real-time quantitative PCR
and ELISA, respectively. The results are shown in (A,B). *P < 0.05, **P < 0.01.
n = 5 per group.
expression between untreated wild type and Cat C KD mice
(Supplementary Figure 5C). In addition, there were no apparent
differences in myelin status shown by MBP IHC and Black
Gold staining (Supplementary Figures 1D–F,G,I,J), but after
4 weeks of cuprizone feeding, CXCL2 mRNA expression was
significantly decreased in Cat C KD mice compared to wild
type mice (Figure 7A). Additionally, both the CD45-positive and
Iba-1-positive cells were also decreased (Figures 7B,C). More
importantly, as we expected, the demyelination in Cat C KDmice
was relieved (Figures 7D,E).
DISCUSSION
In the present study, severe demyelination and inflammatory
responses were observed in cuprizone-treated Cys F KO mice,
implying that Cys F deficiency resulting in disinhibition of Cat
C and subsequent up-regulation of CXCL2 expression might
aggravate the demyelination in the cuprizone model.
Cys F belongs to type II cystatin, which is selectively expressed
in immune cells and is secreted as an inactive disulphide-linked
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FIGURE 7 | Demyelination in Cat C KD mice was relieved accompanying decreased CXCL2 expression and the infiltration of bone marrow-derived
cells after 4-week cuprizone treatment. (A) The expression of CXCL2 mRNA were measured by real-time quantitative PCR. (B) CD45 IHC positive cells in corpus
callosum. (C) Iba-1 IHC positive cells in corpus callosum. (D) The remaining myelin status in corpus callosum shown by MBP IHC staining. (E) The remaining myelin in
corpus callosum shown by Black Gold stainning. *P < 0.05, n = 3 per group. Scale bar: 100µm.
dimer until it is reduced to its monomeric form with proteolytic
cleavage on its extended N-terminal region (Cappello et al.,
2004; Langerholc et al., 2005). Cys F can strongly inhibit Cat
C activity and co-localize with Cat C in murine mast cells
and the Cat C substrate granzyme A in human CD8 T cells
(Hashimoto et al., 2000). Furthermore, our previous studies
showed that in demyelinating animal models, Cys F is co-
localized with Cat C, but not co-localized with cathepsin S
and L in microglia/macrophages (submitted for publication),
although Cys F tightly inhibited cathepsins S and L in other cell
types (Hashimoto et al., 2000). Cat C, or dipeptidyl peptidase I
(DPPI), modulates inflammatory responses by activating serine
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proteases in a number of inflammation models (Pham and
Ley, 1999; Wolters et al., 2001; Adkison et al., 2002; Pottier
et al., 2007; Akk et al., 2008). Specifically, Cat C knockout
mice are completely resistant to acute arthritis in a collagen-
induced rheumatoid arthritis model (Adkison et al., 2002; Hu
and Pham, 2005) and a lack of Cat C alleviates development
of experimental abdominal aortic aneurysms by reducing the
release of CXC-chemokine ligand (CXCL)2 (Pagano et al., 2007;
Shi, 2007). Furthermore, in our previous study, in addition
to the demyelination process, up-regulated Cat C was also
found in LPS-induced neuroinflammation (Fan et al., 2012).
These findings suggest that Cat C might be the key factor
causing severe demyelination in cuprizone-treated Cys F KO
mice.
The cuprizone model is commonly used in the study of
demyelinating diseases due to the reproducible, localized,
and predictable features. Cuprizone-induced demyelination
is thought to be caused by selective toxicity of cuprizone
to oligodendrocytes, specifically through disruption in the
mitochondrial complex IV of myelin-forming cells (Acs
et al., 2013; Bénardais et al., 2013). In this toxin model,
microglia/macrophages actively contribute to the demyelination
process (Liu J. et al., 2015). These microglia/macrophages
accumulate in the demyelinated areas even though the integrity
of the blood-brain barrier is intact in the cuprizone model
(McMahon et al., 2001). Furthermore, some studies have
demonstrated that circulating CXCR2-positive neutrophils are
also important for a two-hit process of cuprizone-induced
demyelination (Liu et al., 2010). In the present study, we found
a significantly increased number of microglia/macrophages
accumulated in demyelinated areas in Cys F KO mice, which
may be associated with chemoattraction mediated by CXCL2.
CXCL2, a member of the CXC chemokine family, also called
macrophage inflammatory protein 2-alpha (MIP2-alpha),
is produced not only by leukocytes (Gu et al., 1999) in
the circulatory system, but also by microglia/macrophages
(Wang et al., 2000; Rouault et al., 2013) and astrocytes
(Wang et al., 2014) in the CNS. CXCL2 mobilizes cells by
interacting with a cell surface chemokine receptor (CXCR2),
whose expression has been identified on many types of
resident cells in the CNS, including neurons and glial cells
(Goczalik et al., 2008), and leukocytes, including neutrophils,
monocytes, and T cells in the peripheral system (Liu Y. et al.,
2015).
The previous studies found that CXCL2 expression was
significantly induced in encephalomyelitis mouse model with
chronic demyelination (Rubio et al., 2006). Moreover, CXCL2
level was up-regulated in rat brain cell cultures subjected
to lysophosphatidylcholine (LPC) accompanying obvious
demyelination and inflammatory reactivity (Defaux et al., 2010).
In our study, CXCL2 expression was induced in mixed-cultured
glial cells following treatment of exogenous Cat C in vitro. In
vivo, up-regulated Cat C expression was found in Cys F KOmice
after 4 weeks of cuprizone feeding, suggesting that despite of
proteolitic properties, Cat C might not be directly involved in
myelin sheath protein degradation, but could play a unique role
in the demyelination process, such as stimulating glial cells to
secrete CXCL2 and thereby attract more inflammatory cells. In
addition, these infiltrated cells might express more Cat C protein
because we and others have demonstrated that Cat C can be
produced by leukocytes in the peripheral system and microglia
in the CNS (Fan et al., 2012; Vidal et al., 2013). Therefore, we
assumed that significantly up-regulated expression of Cat C
after 4-week cuprizone treatment was associated with more
recruitment of inflammatory cells expressing excessive Cat C,
which was consistent with “two-hit” course (Liu et al., 2010).
This assumption can be strengthened by the results showing
that CXCL2 level, inflammatory cell number and demyelinating
degree were significantly reduced in the cuprizone model of Cat
C KD mice, compared with wild type mice.
CONCLUSIONS
Cys F deficiency leading to disinhibition of Cat C aggravates the
demyelination in the cuprizonemodel, whichmight be associated
with up-regulated CXCL2 expression and resulting attraction
of inflammatory cells. Cat C and Cys F could be a promising
therapeutic target for alleviating demyelination.
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Supplementary Figure 1 | The myelin status in untreated mice including
wild type, Cys F KO and Cat C KD mice. PLP IHC staining was performed in
the untreated wild type and Cys F KO mice (A,B); MBP IHC staining was
performed in the untreated wild type and Cat C KD mice (D,E); Black Gold
staining was performed in the untreated wild type, Cys F KO and Cat C KD mice
(G–I). Percentage of remaining myelin in corpus callosum is shown in (C,F,J).
n = 6 per group. Scale bar in (A,B,D,E,G–I): 200µm.
Supplementary Figure 2 | The negative expression of Cat C mRNA in
corpus callosum in untreated wild type and Cys F KO mice. Cat C ISH
staining was performed in the untreated wild type mice (A) and Cys F KO mice
(B). n = 6 per group. Scale bar in (A,B): 200µm.
Supplementary Figure 3 | Themicroglia/macrophagesin corpus callosum
in untreated wild type and Cys F KO mice. Iba-1 IHC (A,B) and c-fms ISH
(D,E) staining were performed in untreated wild type and Cys F KO mice.
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Quantitative analyses of Iba-1 and c-fms positive cells in corpus callosum are
shown in (C,F). n = 4 per group. scale bar in (A,B,D,E):200µm.
Supplementary Figure 4 | CD45 positive expression in untreated wild type
and Cys F KO mice. CD45 IHC staining was performed in untreated wild type
mice (A) and Cys F KO mice (B), respectively. Quantitative analysis of CD45
positive cells in corpus callosum is shown in (C). n = 4 per group. scale bar in
(A,B): 200 µm.
Supplementary Figure 5 | The expression of CXCL2 mRNA and protein in
the brain of untreated wild type, Cys F KO and Cat C KD mice. Real time
quantitative PCR data are shown in (A,C), ELISA result in (B). n = 6 per group.
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